英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

请选择你想看的字典辞典：

单词	字典	翻译
975680	查看　975680　在百度字典中的解释	百度英翻中〔查看〕
975680	查看　975680　在Google字典中的解释	Google英翻中〔查看〕
975680	查看　975680　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://par.freemd5.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://par.freemd5.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Pharvaris | Late-Stage Biopharma Company Focused on HAE
Pharvaris is a late-stage biopharma company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks
Pharvaris clocks a pivotal win in race for rapid HAE relief
Pharvaris hit its primary endpoint, positioning the biotech to file for approval of a challenger to KalVista’s Ekterly in a rare genetic disease
Pharvaris (PHVS): The $300M Biotech that Could Be the Next Big Thing in . . .
Pharvaris N V is a clinical-stage biopharmaceutical company dedicated to developing novel oral therapies for patients suffering from hereditary angioedema (HAE) and other bradykinin-mediated diseases
Pharvaris N. V. (PHVS) - Yahoo Finance
Find the latest Pharvaris N V (PHVS) stock quote, history, news and other vital information to help you with your stock trading and investing
Clinical Pipeline - B2 Receptor Antagonism | Pharvaris
Pharvaris is developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema
Careers - Pharvaris
Pharvaris is a Nasdaq listed late-stage biotech company developing bradykinin B2 receptor antagonists for bradykinin-mediated diseases, with offices in Switzerland (Zug), the Netherlands (Leiden) and the USA (greater Boston area)
About Us - Pharvaris
Pharvaris is a late-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with significant unmet need, initially focused on bradykinin-mediated angioedema and other bradykinin-mediated diseases
Investor Relations - Pharvaris N. V.
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema
News Releases - Pharvaris N. V.
ZUG, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris N V (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema
Disease Focus - HAE Bradykinin-Mediated Diseases - Pharvaris
Pharvaris is developing therapies for people living with HAE, a rare and potentially life-threatening genetic disease, and other bradykinin-mediated diseases

中文字典-英文字典 2005-2009